-
Viewpoint: How 3Ps can deliver new drugs for world’s biggest killer
Imagine a disease that is the world’s biggest killer, with 1.5 million people dying from it each year. It is a disease that touches every country, but some, such as South Africa, Uzbekistan and India, have been hit particularly hard. This disease has a treatment which, in its simplest form, takes six months to complete.
- Categories
- Health Care
-
How to Make a Hardware Store Drill Into a Surgical Tool
When it comes to global public health, a lot of effort goes towards stamping out disease like HIV, malaria, and tuberculosis—and rightly so. These are plagues in many parts of the world. But something we typically focus less energy on, is surgery.
- Categories
- Health Care, Technology
-
Serum Institute to launch a new vaccine every year, says Poonawala
Pune-based vaccines maker Serum Institute plans to launch a new vaccine every year and will launch the first ever synthetic vaccine for rabies by the year-end, CEO, Adar Poonawala, has said.
- Categories
- Health Care, Technology
- Region
- South Asia
-
Latin America Zika Outbreak Should ‘Burn Out’ Within 3 Years, Scientists Say
A team of British experts in disease outbreaks believes that the Zika epidemic afflicting Latin America will end within three years. They based their estimate on modeling using available data on the outbreak, which has so far involved thousands of cases of Zika-linked birth defects, mainly in Brazil.
- Categories
- Health Care
- Region
- Latin America
-
A proposal to build public health capacity in developing nations
In 2005, the World Health Assembly adopted a revised version of its International Health Regulations, a legally binding treaty among 196 nations to boost global health security and strengthen the world’s capacity to confront serious disease threats such as Ebola and SARS. A decade later, just one-third of countries have the ability to respond to a public health emergency. That’s why Rebecca Katz thinks it’s time to get creative.
- Categories
- Health Care
-
Austrian Biotech Plans Zika Vaccine Clinical Trials in 12 Months
An Austrian biotech company working with the Institut Pasteur said on Tuesday it planned to start clinical trials with an experimental Zika vaccine in the next 12 months, marking a further acceleration of research in the field.
- Categories
- Health Care
- Region
- Europe & Eurasia
-
The Dark Ages of Medicine Are Looming. Can He Save Us?
Sean Brady loves dirt. He’s got an entire closetful of it, in classically brown, cobalt blue and flashy orange. It can come from all over the world, from Mongolian steppes to Little League Baseball diamonds. The exotic stuff is what he really craves, but who knows? Maybe he could find a lifesaving antibiotic in your backyard.
- Categories
- Health Care
-
Swine Flu Adds to Brazil’s Zika Worries
Brazil, which will host the Olympics beginning Aug. 5, was already beset by economic problems, a political crisis and the Zika outbreak. Now it's experiencing its worst swine flu outbreak since 2009. Dr. Melvin Sanicas, a program officer at the Bill & Melinda Gates Foundation, wonders if this will be the crisis that forces a change to the Olympic schedule.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.